Literature DB >> 13483658

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

A CARLSSON, M LINDQVIST, T MAGNUSSON.   

Abstract

Entities:  

Keywords:  DOPA/effects; NERVOUS SYSTEM/effect of drugs on; RESERPINE/antagonists; TRYPTOPHAN/related compounds

Mesh：

Substances：

Year:  1957        PMID： 13483658     DOI： 10.1038/1801200a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  214 in total

1.  Synaptic transmission: a story of successive successes.

Authors:  G Stock
Journal:  J Mol Med (Berl)       Date:  2001-07       Impact factor: 4.599

2.  EFFECT OF CATECHOLAMINE PRECURSORS AND PHENYLETHYLAMINES ON SPONTANEOUS ACTIVITY AND ON THE RESPONSE TO METHOHEXITAL ANAESTHESIA.

Authors:  P K LEE; M H CHO; A B DOBKIN
Journal:  Can Anaesth Soc J       Date:  1965-03

3.  Regional neurochemistry and its application to brain function.

Authors:  S S KETY
Journal:  Bull N Y Acad Med       Date:  1962-12

4.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

5.  [On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6].

Authors:  R DEGKWITZ; R FROWEIN; C KULENKAMPFF; U MOHS
Journal:  Klin Wochenschr       Date:  1960-02-01

6.  [Decrease of the effect of noradrenalin on isolated aorta by inhibition of monoaminoxydase].

Authors:  H P BAECHTOLD; A PLETSCHER
Journal:  Experientia       Date:  1959-07-15

Review 7.  A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.

Authors:  Annalisa Pinna; Micaela Morelli
Journal:  Neurotox Res       Date:  2013-12-10       Impact factor: 3.911

8.  Behavioural and somatic effects of bradykinin injected into the cerebral ventricles of unanaesthetized rabbits.

Authors:  F G Graeff; I R Pelá; M Roch e Silva
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

Review 9.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

Review 10.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.